Company: SUPN
Filing Date: 2025-01-27
Form Type: 8-K
Source: 0001356576-25-000002
Chunk: 0

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-01-27
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01

Other Events.

On January 27, 2025, Supernus Pharmaceuticals, Inc. (“ Supernus” or the “ Company”) issued a press release announcing a label update for its non-stimulate attention deficit hyperactivity disorder treatment, Qelbree, to include new pharmacodynamic data and information for breastfeeding women.

A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.